Zantac and omeprazole are not the same medication. They belong to different drug classes, work through different mechanisms, and are suited to different situations. The original Zantac contained ranitidine, an H2 blocker, but was pulled from the market in 2020. The current product sold as Zantac 360 contains famotidine, also an H2 blocker. Omeprazole (sold as Prilosec) is a proton pump inhibitor, or PPI, a more powerful type of acid reducer.
How Each Drug Reduces Stomach Acid
Your stomach lining has specialized cells that pump out acid. These cells can be triggered by several chemical signals, one of which is histamine. H2 blockers like famotidine (current Zantac 360) work by blocking histamine from reaching those cells, which reduces one of the signals telling your stomach to produce acid.
Omeprazole takes a more aggressive approach. Instead of blocking a single trigger, it shuts down the acid pump itself, the final step in acid production. This makes PPIs substantially more effective at suppressing acid output. The trade-off is that omeprazole needs time to build up: it can take one to four days to reach full effect, and the capsule must be swallowed whole. Famotidine, by contrast, starts working within about 15 to 60 minutes and provides relief for up to 12 hours.
Why the Original Zantac Was Pulled
In 2020, the FDA requested that all ranitidine products, including the original Zantac, be removed from the market immediately. The issue was a contaminant called NDMA, a probable human carcinogen. FDA testing found that NDMA levels in ranitidine increased over time even under normal storage conditions, and rose significantly at higher temperatures. The older the product, the higher the contamination.
Importantly, the FDA’s testing found no NDMA in famotidine (Pepcid), omeprazole (Prilosec), or other common heartburn drugs. The problem was specific to the ranitidine molecule itself, not the broader class of acid reducers. The brand name Zantac was later relaunched with famotidine as its active ingredient, the same compound in Pepcid.
When Each One Makes More Sense
If you get heartburn occasionally, after a spicy meal or a late dinner, famotidine is the better fit. It works fast and wears off within half a day. Over-the-counter omeprazole products are specifically not meant for occasional heartburn or immediate symptom relief.
For chronic acid reflux (GERD) or erosive esophagitis, where stomach acid is damaging the lining of your esophagus over time, PPIs like omeprazole are the standard treatment. Large-scale studies have consistently shown that PPIs are superior to H2 blockers for both symptom relief and healing of esophageal damage. They reduce relapse rates more effectively as well. Some people with persistent nighttime symptoms while already taking a PPI will add an H2 blocker at bedtime for extra overnight acid control, though that benefit tends to fade after a few days of regular use.
Available Dosages
Over-the-counter famotidine comes in 10 mg and 20 mg tablets, including chewable versions. Prescription famotidine goes up to 40 mg. Over-the-counter omeprazole is available as a 20 mg capsule or tablet. Prescription omeprazole ranges from 10 mg to 40 mg capsules. The OTC versions of both drugs are widely available at pharmacies without a prescription.
Side Effects and Long-Term Risks
For short-term use, both drugs are generally well tolerated. The bigger concern applies to omeprazole and other PPIs when taken for extended periods. Short-term PPI use is defined as eight weeks or less. Use beyond that, especially for a year or longer, has been linked to a list of potential problems: bone fractures, low magnesium levels, vitamin B12 deficiency, kidney disease, and an increased risk of certain gut infections.
The kidney risk is particularly worth understanding. Research from Washington University School of Medicine found that prolonged PPI use can lead to gradual, silent kidney damage. More than half of patients who developed chronic kidney problems while taking PPIs never experienced acute kidney symptoms beforehand. The decline happens slowly, without obvious warning signs, and in severe cases can progress to kidney failure requiring dialysis or transplant.
The FDA has issued specific safety communications about PPI-associated risks, including gut infections and low magnesium. None of this means omeprazole is unsafe for people who genuinely need it. Erosive esophagitis left untreated carries its own serious risks. But it does mean that taking a PPI indefinitely “just in case” is not a neutral decision. If your symptoms are mild or infrequent, famotidine carries fewer long-term concerns.
The Key Differences at a Glance
- Drug class: Famotidine (Zantac 360) is an H2 blocker; omeprazole (Prilosec) is a proton pump inhibitor.
- Speed: Famotidine works in 15 to 60 minutes. Omeprazole takes one to four days for full effect.
- Strength: Omeprazole suppresses acid more powerfully and is preferred for chronic GERD and esophageal healing.
- Best use: Famotidine for occasional heartburn; omeprazole for persistent or erosive reflux disease.
- Long-term safety: Extended PPI use carries more documented risks than H2 blockers, particularly for kidney health, bone density, and nutrient absorption.